UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)*
Exide Technologies
--------------------------------------------
(Name of Issuer)
Common Stock
----------------------------------------------------
(Title of Class of Securities)
302051206
------------------------
(CUSIP Number)
January 26, 2005
----------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
Page 1 of 5 Pages
SCHEDULE 13G
--------------------- -----------------
CUSIP No. 302051206 Page 2 of 5 Pages
--------------------- ------------------
===========================================================================
Name of Reporting Persons (entities only).
I.R.S. Identification Nos. of Above Persons
MELLON HBV ALTERNATIVE STRATEGIES LLC
---------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ] (b) [ ]
---------------------------------------------------------------------------
3 SEC Use Only
---------------------------------------------------------------------------
4 Citizenship or Place of Organization
United States of America
--------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
---------------------------------------------------------------------------
Number of Shares 5 Sole Voting Power
Beneficially Owned by 1,405,816
Each Reporting Person
With
---------------------------------------------------------------------------
6 Shared Voting Power
0
---------------------------------------------------------------------------
7 Sole Dispositive Power
1,405,816
---------------------------------------------------------------------------
8 Shared Dispositive Power
0
--------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned By Each Reporting Person
1,405,816
---------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes
Certain Shares (See Instructions) [ ]
---------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
5.8%
---------------------------------------------------------------------------
12 Type of Reporting Person (see Instructions)
IA
===========================================================================
Page 3 of 5 Pages
SCHEDULE 13G
Item 1.
(a) Name of Issuer:
Exide Technologies (the "Company")
(b) Address of Issuer's Principal Executive Office:
Crossroads Corporate Center
3150 Brunswick Pike, Suite 230
Lawrenceville, NJ 08648
Item 2. Name of Person Filing
(a) Name of Person Filing:
Mellon HBV Alternative Strategies LLC
(b) Address of Principal Office:
200 Park Avenue
Suite 3300
New York, New York 10166-3399
(c) Citizenship:
The Reporting Person is a Delaware limited liability
company.
(d) Title of Class of Securities: Common Stock
(e) CUSIP Number: 302051206
Item 3. If Statement is filed pursuant to Rules 13(d)-1(b) or 13d-2(b),
check whether Person Filing is a
Not Applicable.
(a) [ ] Broker or dealer registered under section 15 of the
Act (15 U.S.C. 78o);
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15
U.S.C. 78c);
(c) [ ] Insurance company as defined in section 3(a)(19) of
the Act (15 U.S.C. 78c);
(d) [ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e) [ ] An investment adviser in accordance with ss.
240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in
accordance with ss. 240.13d-1(b)(1)(ii)(F)
Page 4 of 5 Pages
(g) [ ] A parent holding company or control person in
accordance with ss. 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition
of an investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with ss.
240.13d-1(b)(1)(ii)(J).
Item 4. Ownership
( a) Amount Beneficially Owned:
The Reporting Person owns 1,405,816 shares of the Company's
Common Stock (the "Shares"). The Reporting Person serves as
investment adviser of certain clients (collectively, the
"Clients"). None of the Clients individually owns more than
5% but the Clients collectively hold the Shares. The
Reporting Person has sole voting and dispository power of
the shares of the Company's Common Stock held by each
Client.
(b) Percentage of Class:
5.8%
(c) Number of shares of which such person has:
(i) power to vote or to direct the vote:
1,405,816
(ii) Shared power to vote or to direct the vote
0
(iii) Sole power to dispose or to direct the disposition of:
1,405,816
(iv) Shared Dispositive Power:
0
Item 5. Ownership of Five Percent or Less of a Class
Not Applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person
The Reporting Person serves as investment adviser of the Clients. The
Reporting Person has sole voting and dispository power of the shares of the
Company's Common Stock held by each Client.
Page 5 of 5 Pages
Item 7. Identification and Classification of Members of the Subsidiary
Which Acquired the Securities Being Reported on by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not Applicable.
Item 9. Notice of Dissolution of Group.
Not Applicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of our knowledge and belief, we
certify that the information set forth in this statement is true, complete and
correct.
Date: February 7, 2005
MELLON HBV ALTERNATIVE STRATEGIES LLC
By: /s/ WILLIAM F. HARLEY III
Name: William F. Harley III
Title: President and Chief Executive Officer